Cargando…

Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis

Over years, the regular use of cannabis has substantially increased among young adults, as indicated by the rise in cannabis use disorder (CUD), with an estimated prevalence of 8. 3% in the United States. Research shows that exposure to cannabis is associated with hypodopaminergic anhedonia (depress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blum, Kenneth, Khalsa, Jag, Cadet, Jean Lud, Baron, David, Bowirrat, Abdalla, Boyett, Brent, Lott, Lisa, Brewer, Raymond, Gondré-Lewis, Marjorie, Bunt, Gregory, Kazmi, Shan, Gold, Mark S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044913/ https://www.ncbi.nlm.nih.gov/pubmed/33868044 http://dx.doi.org/10.3389/fpsyt.2021.623403

Ejemplares similares

A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing “Precision Behavioral Management”
por: Blum, Kenneth, et al.
Publicado: (2021)

Cannabis/Cannabinoids for Treating COVID-19 Associated Neuropsychiatric Complications
por: Khalsa, Jag H., et al.
Publicado: (2021)

Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation
por: Blum, Kenneth, et al.
Publicado: (2022)

Neurogenetics and Epigenetics of Loneliness
por: Bowirrat, Abdalla, et al.
Publicado: (2023)

Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape
por: Blum, Kenneth, et al.
Publicado: (2017)

Hypodopaminergic state of the nigrostriatal pathway drives compulsive alcohol use
por: Goutaudier, Raphaël, et al.
Publicado: (2022)

Neurogenetic and Epigenetic Aspects of Cannabinoids
por: Dennen, Catherine A., et al.
Publicado: (2022)

Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions
por: Blum, Kenneth, et al.
Publicado: (2021)

The Link between Cannabis Use, Immune System, and Viral Infections
por: Maggirwar, Sanjay B., et al.
Publicado: (2021)

Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis”
por: Braverman, Eric R., et al.
Publicado: (2022)

High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial
por: Moran, Mark, et al.
Publicado: (2021)

Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder (SUD)
por: Blum, K, et al.
Publicado: (2019)

Review: Cannabinoids as Medicinals
por: Khalsa, Jag H., et al.
Publicado: (2022)

Protracted Abstinence From Extended Cocaine Self-Administration Is Associated With Hypodopaminergic Activity in the VTA but Not in the SNc
por: Salin, Adélie, et al.
Publicado: (2020)

Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?
por: Gold, Mark S., et al.
Publicado: (2020)

Calvin klein (CK) designer cocktail, new “Speedball” is the “grimm reaper”: Brain dopaminergic surge a potential death sentence
por: Gold, Mark S, et al.
Publicado: (2020)

Opioid and dopamine genes interact to predict precision naltrexone response in alcohol use disorder: Interpretation misfires
por: Blum, Kenneth, et al.
Publicado: (2021)

Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case–Control Subjects
por: Blum, Kenneth, et al.
Publicado: (2022)

Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis
por: Blum, Kenneth, et al.
Publicado: (2023)

Addiction by Any Other Name is Still Addiction: Embracing Molecular Neurogenetic/Epigenetic Basis of Reward Deficiency
por: Edwards, Drew, et al.
Publicado: (2020)

Mechanisms of Sleep/Wake Regulation under Hypodopaminergic State: Insights from MitoPark Mouse Model of Parkinson's Disease
por: Fifel, Karim, et al.
Publicado: (2022)

Hypothesizing That Pediatric Autoimmune Neuropsychiatric Associated Streptococcal (PANDAS) Causes Rapid Onset of Reward Deficiency Syndrome (RDS) Behaviors and May Require Induction of “Dopamine Homeostasis”
por: Blum, Kenneth, et al.
Publicado: (2022)

Gene variants and educational attainment in cannabis use: mediating role of DNA methylation
por: Gerra, Maria Carla, et al.
Publicado: (2018)

Anhedonia, Apathy, Pleasure, and Effort-Based Decision-Making in Adult and Adolescent Cannabis Users and Controls
por: Skumlien, Martine, et al.
Publicado: (2022)

Genetic Addiction Risk and Psychological Profiling Analyses for “Preaddiction” Severity Index
por: Blum, Kenneth, et al.
Publicado: (2022)

Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usual
por: Blum, Kenneth, et al.
Publicado: (2020)

Divergent effects of acute and repeated quetiapine treatment on dopamine neuron activity in normal vs. chronic mild stress induced hypodopaminergic states
por: Moreines, Jared L., et al.
Publicado: (2017)

Apathy and Anhedonia in Adult and Adolescent Cannabis Users and Controls Before and During the COVID-19 Pandemic Lockdown
por: Skumlien, Martine, et al.
Publicado: (2021)

P.0286 Apathy and anhedonia in adult and adolescent cannabis users and controls before and during the coronavirus lockdown
por: Skumlien, M., et al.
Publicado: (2021)

Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It “Blowin’ in the Wind”?
por: Blum, Kenneth, et al.
Publicado: (2022)

Amphetamine recapitulates developmental programs in the zebrafish
por: Cadet, Jean Lud
Publicado: (2009)

Epigenetics of Stress, Addiction, and Resilience: Therapeutic Implications
por: Cadet, Jean Lud
Publicado: (2014)

Dysregulation of Acetylation Enzymes in Animal Models of Psychostimulant use Disorders: Evolving Stories
por: Cadet, Jean Lud
Publicado: (2016)

Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine
por: Abijo, Tomilowo, et al.
Publicado: (2020)

Neurobiological mechanisms of anhedonia
por: Gorwood, Philip
Publicado: (2008)

Anhedonia and Depressive Disorders
por: Serretti, Alessandro
Publicado: (2023)

Hepatitis C Virus Infection in Persons Who Inject Drugs in the Middle East and North Africa: Intervention Strategies
por: Khalsa, Jag H., et al.
Publicado: (2021)

Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?
por: Gondré-Lewis, Marjorie C., et al.
Publicado: (2022)

The Primacy of Cognition in the Manifestations of Substance Use Disorders
por: Cadet, Jean Lud, et al.
Publicado: (2013)

Glial-neuronal ensembles: partners in drug addiction-associated synaptic plasticity
por: Cadet, Jean Lud, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nppt4418a1kflu9ehk1bsin4f0